Categories Earnings, Health Care

Veeva Systems (NYSE: VEEV): Q3 2020 Earnings Snapshot

— Veeva Systems Inc. (NYSE: VEEV) reported its third-quarter 2020 adjusted earnings of $0.60 per share versus $0.54 per share expected.

— Total revenue jumped by 25% to $280.9 million versus $274.78 million expected. This was driven by a 27% growth in the subscription services revenue.

Earnings Update by AlphaStreet

— The top line primarily comes from the fees from customers accessing cloud-based software solutions and subscription or license fees for data solutions.

— Looking ahead into the fourth quarter, the company expects revenues in the range of $296-299 million and adjusted earnings of $0.51-0.52 per share. The consensus estimates EPS of $0.52 on revenue of $279.86 million.

— For the full year 2020, the company lifted its revenue outlook to the range of $1.088 billion to $1.091 billion from the previous range of $1.062 billion to $1.065 billion. The consensus estimates revenue of $1.07 billion.

— The adjusted earnings guidance is raised to the range of $2.16 to $2.17 per share from the prior range of $2.11 to $2.13 per share. The analysts expect EPS of $2.12 for the full year.

Listen to publicly listed companies’ earnings conference calls along with the edited closed caption text.

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top